GAVIOLI, Riccardo
 Distribuzione geografica
Continente #
NA - Nord America 9.863
EU - Europa 3.062
AS - Asia 1.812
SA - Sud America 11
OC - Oceania 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.757
Nazione #
US - Stati Uniti d'America 9.840
CN - Cina 912
PL - Polonia 724
UA - Ucraina 656
IT - Italia 462
SG - Singapore 429
DE - Germania 412
TR - Turchia 359
GB - Regno Unito 305
SE - Svezia 189
FI - Finlandia 144
BE - Belgio 67
ID - Indonesia 42
FR - Francia 41
VN - Vietnam 23
CA - Canada 22
IR - Iran 17
NL - Olanda 15
IN - India 13
CZ - Repubblica Ceca 12
LT - Lituania 12
HK - Hong Kong 8
RU - Federazione Russa 7
BR - Brasile 5
AU - Australia 4
IE - Irlanda 4
RO - Romania 4
AT - Austria 3
CL - Cile 3
VE - Venezuela 3
ES - Italia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
DK - Danimarca 1
EU - Europa 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
LU - Lussemburgo 1
MN - Mongolia 1
MX - Messico 1
OM - Oman 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 14.757
Città #
Fairfield 1.283
Woodbridge 1.108
Houston 877
Jacksonville 728
Ann Arbor 726
Warsaw 724
Chandler 684
Ashburn 626
Seattle 503
Wilmington 451
Cambridge 439
Singapore 335
Santa Clara 325
Izmir 230
Ferrara 207
Beijing 191
Nanjing 181
Princeton 149
San Diego 144
Boardman 107
New York 100
Shanghai 84
Milan 78
Los Angeles 68
Shenyang 68
Brussels 67
Nanchang 55
Munich 50
Dearborn 49
Addison 45
San Mateo 45
Hebei 42
Jakarta 42
Tianjin 39
Changsha 38
Bremen 37
Jinan 37
Falls Church 36
Bologna 34
Jiaxing 31
Mountain View 27
London 26
Dong Ket 23
Auburn Hills 21
Ningbo 17
Norwalk 17
Ardabil 16
Des Moines 16
Redwood City 16
Zhengzhou 15
Modena 14
Tappahannock 14
Helsinki 13
Kunming 13
Toronto 13
Brno 12
Philadelphia 12
Guangzhou 11
Leawood 11
Orange 11
Rome 11
Verona 11
Indiana 10
Ferrara di Monte Baldo 9
Hefei 9
Amsterdam 8
Lanzhou 8
Ottawa 8
Augusta 7
Frankfurt am Main 7
Hong Kong 7
Taizhou 7
Washington 7
Fuzhou 6
Hangzhou 6
Haikou 5
Redmond 5
Chicago 4
Dublin 4
Hounslow 4
Acton 3
New Bedfont 3
Novosibirsk 3
Parma 3
San Francisco 3
São Paulo 3
Vienna 3
Chiswick 2
Clifton 2
Crevalcore 2
Edinburgh 2
Forest City 2
Hull 2
Kilburn 2
Madrid 2
Monmouth Junction 2
Padova 2
Phoenix 2
Pontassieve 2
Prescot 2
Totale 11.571
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 263
Identification of new HIV-1 Gag-specific cytotoxic T lymphocyte responses in BALB/c mice 254
null 183
null 179
Systemic immunodominant CD8 responses with an effector-like phenotype are induced by intravaginal immunization with attenuated HSV vectors expressing HIV Tat and mediate protection against HSV infection 171
null 167
The HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses. 159
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 158
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 147
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors 146
Association between different anti-Tat antibody isotypes and HIV disease progression: Data from an African cohort 145
C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors 142
Evaluation of CR1 expression in neutrophils from chronic myeloid leukaemia: relationship between prognosis and cellular activity 140
Biologically active platinum complexes containing 8-thiotheophylline and 8-(methylthio)theophylline 140
Nafion®-containing solid lipid nanoparticles as a tool for anticancer pt delivery: preliminary studies 139
Vinyl ester-based cyclic peptide proteasome inhibitors 135
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 133
Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors 133
Rational design of nucleoside-bile acid conjugates incorporating a triazole moiety for anticancer evaluation and SAR exploration 133
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 133
New class of proteasome 20S inhibitors: a crystallographic and molecular modelling study 130
Modulation of neutrophil functions by activated platelet release factors 129
Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides 129
Arecoline tripeptide inhibitors of proteasome 127
Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors 125
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells 123
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (ii) carboxylates 123
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 121
An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins 118
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 118
Peptide analogues of a subdominant epitope expressed in EBV-associated tumors: synthesis and immunological activity 118
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 117
Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8 117
P3 and P4 position analysis of vinyl ester pseudopeptide proteasome inhibitors 116
Phosphinic platinum complexes with 8-thiotheophylline derivatives: Synthesis, characterization, and antiproliferative activity 116
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells 116
Dual mechanism in induction of human neutrophil cytotoxicity: activation of protein kinase C and elevation in intracellular calcium 115
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 115
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 115
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 115
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 113
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 113
UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion 113
Deficiency of neutrophil membrane antigen detected by monoclonal antibody in rheumatoid arthritis 112
Peptidyl vinyl ester derivatives: New class of selective inhibitors of proteasome trypsin-like activity 111
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues 111
α,β-Unsaturated N-Acylpyrrole Peptidyl Derivatives: New Proteasome Inhibitors 111
null 110
null 109
IL-8 enhances antibody-dependent cellular cytotoxicity in human neutrophils 108
Novel oleanolic vinyl boronates: synthesis and antitumor activity 108
T-cell engineering by a chimeric T-cell receptor with antibody-type specificity for the HIV-1 gp120 107
Platinum and ruthenium complexes of new long-tail derivatives of PTA (1,3,5-triaza-7-phosphaadamantane): Synthesis, characterization and antiproliferative activity on human tumoral cell lines 107
null 107
NEUTROPHIL CR1 RECEPTOR: RELATIONSHIP BETWEEN EXPRESSION LEVEL AND CYTOTOXICITY IN HEALTHY AND CHRONIC MYELOID LEUKEMIA 106
Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs 106
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors. 105
Design of dimeric peptides obtained from a subdominant Epstein-Barr virus LMP2-derived epitope 105
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 104
The Enigma of Tripeptidyl-Peptidase II: Dual Roles in Housekeeping and Stress 104
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes 104
null 103
Triggering of neutrophil cytotoxicity against an antibody-coated tumour target by TPA 103
Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides 102
null 101
The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity 101
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes 101
Down-regulation of proteolytic complexes following EBV activation in BL cells 100
HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population 99
Immune escape by Epstein-Barr virus (EBV) carrying Burkitt�s lymphoma: In vitro reconstitution of sensitivity to EBV specific cytotoxic T cells 99
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 99
CD16 and CR3 receptors distinguish between the two mechanisms of tumour cytotoxicity in neutrophils 97
Protein kinase C mediates human neutrophil cytotoxicity 96
CULTURED HUMAN FIBROBLASTS ACQUIRE ADHESIVENESS FOR NEUTROPHILS AFTER STIMULATION 96
A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance 96
Recent Advances In The Development Of HIV-1 Tat-Based Vaccines 96
null 95
Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors 95
null 95
N-Terminal-prolonged vinyl ester-based peptides as selective proteasome b1 subunit inhibitors 94
Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus 93
Age-related decline of de novo T cell responsiveness as a cause of COVID-19 severity 93
Expression and functionality of adenosine receptors in human blood cells 92
Intracellular HIV-1 tat protein represses constitutive LMP2 transcription increasing proteasome activity by interfering with the binding of IRF-1 to STAT1 91
Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4 90
null 90
null 90
null 89
c-Myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells 89
ACTION MECHANISM OF ACTIVATORS OF NEUTROPHIL-MEDIATED CYTOTOXICITY 87
null 87
null 87
CHEMOTACTIC RESPONSE OF HUMAN MONOCYTES TOWARDS LINEAR AND CYCLIC PEPTIDE T ANALOG 86
Polymorphonuclear neutrophils pulsed with synthetic peptides efficiently activate memory cytotoxic T lymphocytes. 85
New cyclic peptide proteasome inhibitors 84
null 83
Attivita' tumoricida dei neutrofili 83
"Lab-on-a-Chip" devices for cellular array based on dielectrophoresis 82
null 82
null 81
Totale 11.489
Categoria #
all - tutte 64.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 507
Totale 65.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.133 0 0 0 0 240 384 298 338 265 354 177 77
2020/20212.200 200 190 102 227 94 213 115 254 73 321 288 123
2021/20221.776 53 158 154 112 93 58 116 96 75 119 151 591
2022/20231.594 168 84 78 215 254 230 84 133 192 10 84 62
2023/2024816 80 126 34 27 50 151 35 61 11 22 17 202
2024/20251.022 82 78 290 162 410 0 0 0 0 0 0 0
Totale 14.954